HCP Live

5 criteria for diagnosing ADHD

Oct 2, 2019

Pat F. Bass III, MD, MS, MPH
David O Childers Jr., MD

When determining whether a diagnosis of attention-deficit/hyperactivity disorder (ADHD) is the correct diagnosis, here are 5 important criteria to consider.

Related Videos

Jessica Peck

Related Content

Leniolisib approved as first treatment for PI3K-delta syndrome in patients 12 years and older

March 27th 2023

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023

RSV surged in 2022 but appears to make early retreat in 2023

March 27th 2023

Demystifying Infant Formula

October 11th 2022

FDA approves dabrafenib plus trametinib and liquid formulations to treat BRAF V600E low-grade glioma

March 24th 2023

Poll reveals how parents determine risks, punishments, and likelihood of vaping in their children

March 24th 2023

Leniolisib approved as first treatment for PI3K-delta syndrome in patients 12 years and older

March 27th 2023

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023

RSV surged in 2022 but appears to make early retreat in 2023

March 27th 2023

Demystifying Infant Formula

October 11th 2022

FDA approves dabrafenib plus trametinib and liquid formulations to treat BRAF V600E low-grade glioma

March 24th 2023

Poll reveals how parents determine risks, punishments, and likelihood of vaping in their children

March 24th 2023

Leniolisib approved as first treatment for PI3K-delta syndrome in patients 12 years and older

March 27th 2023

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023

RSV surged in 2022 but appears to make early retreat in 2023

March 27th 2023

Demystifying Infant Formula

October 11th 2022

FDA approves dabrafenib plus trametinib and liquid formulations to treat BRAF V600E low-grade glioma

March 24th 2023

Poll reveals how parents determine risks, punishments, and likelihood of vaping in their children

March 24th 2023

Related Content

FDA | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

Leniolisib approved as first treatment for PI3K-delta syndrome in patients 12 years and older

March 27th 2023

Leniolisib is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023

RSV surged in 2022 but appears to make early retreat 2023 | Image Credit: © zilvergolf - © zilvergolf - stock.adobe.com

RSV surged in 2022 but appears to make early retreat in 2023

March 27th 2023

New maternal vaccine options could offer extra protection in upcoming seasons.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022

FDA Approval | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves dabrafenib plus trametinib and liquid formulations to treat BRAF V600E low-grade glioma

March 24th 2023

Pediatric patients with BRAF V600E low-grade glioma as young as 1 year can now be treated with dabrafenib plus trametinib following its FDA approval.

Teenager vaping | Image Credit: © mariiya - © mariiya - stock.adobe.com.

Poll reveals how parents determine risks, punishments, and likelihood of vaping in their children

March 24th 2023

A recent survey from the C.S. Mott Children’s Hospital National Poll on Children’s Health revealed how addictive parents believe vaping is for children.

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.